Anemarrhena

Asparagaceae

Anemarrhena asphodeloides

Also known as: Zhi Mu, Anemarrhena Rhizome, Know-Mother Root

Pregnancy C
Lactation C

clinical_notes Clinical Summary

Zhi Mu (Anemarrhena asphodeloides) is a cornerstone Chinese yin-nourishing and heat-clearing herb, classified in the 'clears heat and purges fire' category.

Its rhizome contains steroidal saponins (timosaponins, sarsasapogenin) and the xanthone mangiferin, with documented antipyretic, antidiabetic, anti-inflammatory, neuroprotective, and anti-osteoporotic activity.

Best known for treating yang-ming high fever (in Bai Hu Tang) and menopausal yin-deficient heat (in Zhi Bai Di Huang Wan); contraindicated in cold-deficient digestive patterns.

Pregnancy Safety

C

Classical TCM contraindication during pregnancy due to cold nature and downward-moving effect. Insufficient modern safety data. Avoid unless directed by a qualified TCM practitioner.

Lactation Safety

C

Insufficient safety data in lactation. Cold nature may affect milk supply and infant digestion (cold and damp). Use with caution.

warning Contraindications

  • Spleen Yang deficiency / Cold in the Middle Jiao (contraindicated)
    Theoretical
  • Pregnancy (caution)
    Theoretical
  • Chronic diarrhea (avoid)
    Theoretical
  • Concurrent anticoagulant or antiplatelet therapy (caution)
    Theoretical
  • Hypoglycemia / concurrent antidiabetic drugs (caution)
    Theoretical

vital_signs Clinical Profile

Primary Indications

  • check_circle high fever with thirst
  • check_circle yin deficiency with night sweats
  • check_circle menopausal hot flashes
  • check_circle diabetes mellitus (consumptive thirst / xiaoke)
  • check_circle irritability and insomnia from yin deficiency
  • check_circle dry cough
  • check_circle lower back pain (kidney yin deficiency)
  • check_circle steaming bone fever (tuberculosis convalescence)
  • check_circle urinary tract infection with heat

Therapeutic Actions

clears heatdrains firenourishes yinmoistens drynessantipyreticanti-inflammatoryantidiabeticantiplateletantimicrobialneuroprotectiveanti-osteoporotic

System Affinities

  • check_circle Lung
  • check_circle Stomach
  • check_circle Kidney
  • check_circle endocrine
  • check_circle central nervous system
  • check_circle skeletal

labs Active Constituents

timosaponin A-III

timosaponin B-II

sarsasapogenin

anemarsaponin IA

mangiferin

neomangiferin

isomangiferin

polysaccharides

broussonin A and B

phenolic compounds

asphonin

choline

tannins

history_edu Traditional Use

Traditional Chinese Medicine (TCM)

Chinese Name

知母 (Zhi Mu)

Properties

Nature: cold

bittersweet
Meridians / Channels
LungStomachKidney
TCM Indications
  • High fever (Yang Ming heat)
  • consumptive thirst (Xiao Ke)
  • Yin deficiency with night sweats and steaming bone fever
  • irritability and insomnia from yin deficiency
  • dry cough from Lung heat
  • menopausal heat
  • lower back pain (Kidney yin deficiency)
Zang-Fu Organ Patterns
Lung heat with phlegmStomach fire blazingKidney yin deficiency with empty heatYin deficiency with internal heat
Classical Formulas
Bai Hu Tang (White Tiger Decoction)Zhi Bai Di Huang Wan (Anemarrhena, Phellodendron, Rehmannia Pill)Suan Zao Ren Tang (Sour Jujube Decoction)Zhi Mu TangDa Bu Yin Wan (Great Tonify the Yin Pill)Yu Nu Jian (Jade Maiden Decoction)
Notes

Zhi Mu is one of the most important Yin-tonifying and Heat-draining herbs in Chinese Materia Medica. Used 'unprepared' (Sheng Zhi Mu) for clearing excess Yang Ming heat; salt-prepared (Yan Zhi Mu) is preferred for nourishing Kidney yin and clearing deficient heat. Frequently paired with Huang Bai (phellodendron) for yin-deficient heat in lower body and with Shi Gao (gypsum) for Yang Ming fever.

auto_stories

Traditional Uses Across Healing Systems

While many herbs lack controlled clinical trials, centuries of traditional practice across cultures provide valuable insight into their therapeutic applications.

TCM China, Korea, Mongolia, Japan
Documented in Shennong Ben Cao Jing (~200 BCE) — one of the earliest classical Chinese materia medica texts.

Clears heat, drains fire, nourishes yin, moistens dryness; for high fever, irritability, thirst, hot flashes, night sweats, diabetes-related thirst, and dry cough.

Key herb in Bai Hu Tang (White Tiger Decoction) by Zhang Zhongjing (Han dynasty, 200 CE) for Yang Ming heat patterns.

TCM China
Ming Dynasty (~1500 CE)

Classical formula Zhi Bai Di Huang Wan combines Zhi Mu, Phellodendron, and six Rehmannia herbs to treat Kidney yin deficiency with empty fire — menopausal heat, night sweats, hot flushes, low-back pain.

Modern clinical trials of Zhi Bai Di Huang Wan demonstrate significant reduction in vasomotor symptoms in menopausal women.

Kampo Japan
Adopted from TCM tradition (~8th century CE onwards)

Used in Japanese Kampo formulas adapted from Chinese tradition, often for febrile illness and yin-deficiency patterns.

spa Parts Used

rhizome

Constituents
timosaponin A-IIItimosaponin B-IIsarsasapogeninmangiferinpolysaccharides
Indications
  • fever
  • thirst
  • diabetes
  • yin deficiency heat
  • night sweats
  • menopausal symptoms
  • dry cough
  • low back pain
Preparation

Harvested in spring or autumn from 3-4 year old plants. Two main preparations: (1) Sheng Zhi Mu (unprepared) — sliced and dried; cooling, clears excess Yang Ming heat. (2) Yan Zhi Mu (salt-prepared) — stir-fried with salt water; directed to the Kidney to nourish yin and clear deficient heat. Best quality has yellow-white cross-section with sticky mucilage; the 'gold-wrapped head' (jin bao tou) crown is prized.

shield Safety

Contraindications — Evidence Basis

Spleen Yang deficiency / Cold in the Middle Jiao
contraindicated Theoretical

Zhi Mu is cold and moistening; will worsen loose stools, poor appetite, and cold-deficient digestive patterns.

Pregnancy
caution Theoretical

Use with caution. Classical TCM texts caution use in pregnancy due to cold nature; modern data limited.

Chronic diarrhea
avoid Theoretical

Cold and moistening nature exacerbates loose stools and damp-cold patterns.

Concurrent anticoagulant or antiplatelet therapy
caution Theoretical

Timosaponin B-II inhibits blood coagulation and platelet aggregation in animal studies; theoretical additive bleeding risk.

Hypoglycemia / concurrent antidiabetic drugs
caution Theoretical

Mangiferin significantly lowers blood glucose in type 2 diabetic models; additive hypoglycemia possible.

monitoring

Monitoring Parameters

Monitor during use, especially with prolonged or high-dose therapy.

Fasting blood glucose and HbA1c (if diabetic)
Baseline and every 4-12 weeks

Mangiferin lowers blood glucose; may potentiate antidiabetic therapy.

flagThreshold: FBG <70 mg/dL or symptomatic hypoglycemia: reduce dose.

INR (if on warfarin)
More frequent monitoring after initiation

Timosaponin B-II inhibits coagulation and may potentiate warfarin.

flagThreshold: INR >3.5 or supratherapeutic: reduce warfarin dose.

Toxicity

Toxic Dose

Generally well tolerated within therapeutic dose (6-12 g/day decoction). High doses may cause GI upset.

Symptoms

Loose stools, abdominal cramping, nausea at high doses or in cold-deficient individuals.

Management

Discontinue or reduce dose; combine with warming digestive herbs (ginger, dried ginger) to offset cold nature.

Adverse Effects

loose stoolsabdominal coldnessrare hypoglycemia

CYP Metabolism

Mangiferin inhibits CYP3A4 and CYP2C9 in vitro at micromolar concentrations — theoretical interactions with substrates including warfarin, statins, midazolam. Timosaponin B-II modulates intestinal P-gp efflux.

swap_horiz Interactions

Insulin / Sulfonylureas / Metformin

Increased Effect moderate

Class: Antidiabetic

Mechanism

Total saponins, mangiferin, anemarans, and timosaponin B-II from A. asphodeloides have documented hypoglycemic activity through enhanced insulin sensitivity, GLP-1 secretion, and AMPK activation. Additive glucose lowering with antidiabetic agents may cause hypoglycemia.

Clinical Guidance

Monitor fasting and postprandial blood glucose. Consider downward titration of antidiabetic drugs. Educate patients on hypoglycemia recognition and management.

menu_book
Evidence Source Wang Y, Dan Y, Yang D, et al. The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacology. J Ethnopharmacol 2014;153(1):42-60 View source open_in_new

Warfarin

Increased Effect moderate

Class: Anticoagulant

Mechanism

Mangiferin inhibits CYP3A4 (IC50 8.7 μM) and CYP2C9 in vitro; CYP2C9 is the primary metabolic pathway for warfarin (S-enantiomer). Inhibition raises plasma warfarin levels and elevates INR. Timosaponin AIII also has documented anti-platelet aggregation activity.

Clinical Guidance

Monitor INR closely if co-administered. Be prepared to reduce warfarin dose. Counsel patients on bleeding signs. Discontinue Anemarrhena 1-2 weeks before elective surgery.

menu_book
Evidence Source Li X, Li S, Li Y, et al. Mangiferin inhibits the activity of CYP2D6, CYP3A4 and CYP3A5 in human liver microsomes. Pharm Biol 2020;58:1-7 View source open_in_new

Tamoxifen

Decreased Effect high

Class: Selective estrogen receptor modulator

Mechanism

Mangiferin and the Baihe Zhimu formula (containing A. asphodeloides) significantly inhibit CYP450 enzymes responsible for bioactivation of tamoxifen to endoxifen and 4-hydroxytamoxifen (CYP2D6, CYP3A4/5). In mouse xenograft models, Baihe Zhimu reduced tumor-tissue concentrations of active tamoxifen metabolites and attenuated anticancer efficacy.

Clinical Guidance

Avoid co-administration in breast cancer patients on tamoxifen. The clinical risk is reduced efficacy of endocrine therapy. Use alternative herbs without CYP2D6/3A4 inhibition.

menu_book
Evidence Source Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y. Baihe Zhimu formula attenuates the efficacy of tamoxifen against breast cancer in mice through modulation of CYP450 enzymes. BMC Complement Altern Med 2019;19:240 View source open_in_new

CYP3A4 substrates (statins, midazolam, calcium channel blockers, cyclosporine)

Increased Effect moderate

Class: CYP3A4 substrates

Mechanism

Mangiferin inhibits CYP3A4 (IC50 8.7 μM, Ki 10.8 μM) non-competitively. Anemarsaponin BII inhibits CYP3A4 (IC50 13.7 μM). Inhibition may elevate plasma levels of simvastatin, atorvastatin, midazolam, amlodipine, nifedipine, tacrolimus, and cyclosporine.

Clinical Guidance

Monitor for substrate toxicity. Consider therapeutic drug monitoring (cyclosporine, tacrolimus) or alternative agents. Watch for myopathy with statins.

menu_book
Evidence Source Liu Y, Ma H, Zhang L, et al. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes. Pharm Biol 2020;58(1):1131-1136 View source open_in_new

CYP2D6 substrates (codeine, tramadol, metoprolol, fluoxetine, paroxetine)

Decreased Effect moderate

Class: CYP2D6 substrates

Mechanism

Mangiferin inhibits CYP2D6 (IC50 9.2 μM, Ki 3.8 μM). For prodrugs requiring CYP2D6 bioactivation (codeine→morphine, tramadol→O-desmethyltramadol), inhibition reduces analgesic efficacy. For metoprolol, inhibition raises plasma levels and may cause bradycardia/hypotension.

Clinical Guidance

Monitor analgesic response with codeine/tramadol. Consider alternative analgesics. For metoprolol and other CYP2D6 substrates, monitor for substrate toxicity.

menu_book
Evidence Source Li X, Hu J, Wang B, et al. Inhibitory effects of herbal constituents on P-glycoprotein and CYP3A4 in vitro. Mol Med Rep 2020 View source open_in_new

P-glycoprotein substrates (digoxin, fexofenadine, dabigatran)

Increased Effect moderate

Class: P-gp substrates

Mechanism

Timosaponin B-II from A. asphodeloides modulates intestinal P-glycoprotein efflux. Inhibition of P-gp increases bioavailability and plasma levels of digoxin, dabigatran, and fexofenadine.

Clinical Guidance

Monitor digoxin levels (target 0.5-1.0 ng/mL). For dabigatran, watch for bleeding. Consider dose adjustment.

menu_book
Evidence Source Tian X, Xu Z, Li Z, et al. Pharmacokinetics of mangiferin and its metabolite-norathyriol, Part 2: influence of UGT, CYP450, P-gp, and enterobacteria in Rhizoma Anemarrhenae decoction with timosaponin B2 as the major contributor. Biofactors 2016;42:545-555 View source open_in_new

hub Combinations

info

Synergistic pairings can enhance therapeutic outcomes, while knowing suitable substitutes helps when specific herbs are unavailable or contraindicated.

receipt_long

Classical Formulas

2
Rehmannia
Strong Evidence
Rationale

Rehmannia (Shu Di Huang or Sheng Di Huang) is the chief yin-nourishing herb; pairs with Zhi Mu for Kidney yin deficiency and empty heat. Core of Zhi Bai Di Huang Wan.

Clinical Evidence

Modern clinical use for menopausal syndrome, diabetic complications, autoimmune conditions with yin deficiency.

Sour Jujube Seed
Strong Evidence
Rationale

In Suan Zao Ren Tang, Zhi Mu nourishes yin and clears empty heat while suan zao ren nourishes Heart yin and calms shen. Together used for yin-deficient insomnia and anxiety.

Clinical Evidence

Classical Han Dynasty formula (Jin Gui Yao Lue); modern clinical use for insomnia, anxiety, and menopausal sleep disturbance.

link Zhang Zhongjing. Jin Gui Yao Lue (Essentials from the Golden Cabinet). ~220 CE.
auto_awesome

Synergistic Combinations

3
Chinese Skullcap
Traditional Use
Rationale

Huang Qin (Chinese skullcap) clears Lung and upper jiao heat; combined with Zhi Mu treats febrile illness and lung heat patterns.

Clinical Evidence

Common pairing in modern Chinese pharmacology for respiratory infections with high fever.

link Bensky D et al. Chinese Herbal Medicine: Materia Medica. 2004.
Phellodendron
Strong Evidence
Rationale

Classic 'Yin tonic / drain deficient fire' pair. Zhi Mu clears heat in upper and middle burner while Huang Bai (Phellodendron) drains heat from the lower burner. Foundational duo in Zhi Bai Di Huang Wan.

Clinical Evidence

Zhi Bai Di Huang Wan formulation showed significant reduction in menopausal vasomotor symptoms in clinical trials.

White Peony
Traditional Use
Rationale

White peony nourishes Liver Yin and softens; combined with Zhi Mu addresses Liver-Kidney yin deficiency with heat, insomnia, and irritability.

Clinical Evidence

Traditional pairing for menopausal women with irritability and dryness.

link Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. 2004.

science Studies

search

No studies match your criteria.

medication Dosing

decoction

Dose Range

6-12 g dried rhizome

Frequency

1-2x/day

Notes

Standard TCM dose. Boil for 20-30 minutes with other herbs in formula. Often combined with Huang Bai (phellodendron) for yin-deficient heat or Shi Gao (gypsum) for Yang Ming excess heat.

capsule

Dose Range

500 mg dried powder, 3-6 capsules

Frequency

2-3x/day

Notes

Commercial Western formulation. Always take with formula partners — rarely used as monotherapy in TCM.

tincture

Dose Range

2-4 mL of 1:5 tincture in 45% ethanol

Frequency

TID

Notes

Less common but used in Western herbal practice. Adjust based on formula partners.

menu_book
Reference Mills S, Bone K. Principles and Practice of Phytotherapy. 2nd ed. Churchill Livingstone; 2013.

powder

Dose Range

1-3 g granular extract (5:1 concentration)

Frequency

2-3x/day

Notes

Granular extracts (e.g., Sun Ten, KPC) standardized to 5:1. Use within formula structure.

smart_toy

Disclaimer: This information is largely AI-generated and reviewed by human experts at Evara Health. It is intended for educational and clinical reference purposes only and should not replace professional medical advice.

© 2026 Evara Health. All rights reserved.

Clinical Action Center

Export data for clinical use or patient education